流感診斷市場：趨勢、機會與競爭分析 [2023-2028]

流感診斷市場趨勢與預測

預計到2028年，全球流感診斷市場將達到 15 億美元，2023年至2028年年複合成長率為 4.1%。該市場的主要促進因素是慢性病的增加、政府監測流感的措施不斷加強以及技術先進的流感診斷測試的引進。全球流感診斷市場的未來看起來充滿希望，診斷實驗室和醫院/診所市場存在商機。

流感診斷市場洞察

• Lucintel 預測，由於對診斷技術的流感研究數量不斷增加以及世界對該疾病早期診斷的認知不斷增強，分子診斷檢測在預測期內仍將是最大的細分市場。
• 還有，由於醫院數量的增加、人們對流感診斷意識的增強以及對快速診斷檢測設備的需求不斷成長，預計醫院和診所仍將是最大的細分市場。
• 由於人口高齡化加劇、流感患病率上升以及主要參與者的存在，北美仍然是預測期內最大的地區。

本報告回答了 11 個關鍵問題：

• Q.1.細分市場中最有前途和高成長的機會是什麼？
• Q.2.哪些是最有前景和高成長的細分市場？
• Q.3.哪些地區未來會出現更快的成長？為什麼？
• Q.4.影響市場動態的主要要素有哪些？市場的主要挑戰和商業風險是什麼？
• Q.5.這個市場的商業風險和競爭威脅是什麼？
• Q.6.這個市場有哪些新趨勢？為什麼？
• Q.7.市場客戶需求有何改變？
• Q.8.該市場有哪些新發展以及哪些公司處於領先地位？
• Q.9.這個市場的主要企業有哪些？此外，主要企業採取什麼樣的策略配合措施？
• Q10.該市場的競爭產品有哪些？因材料或產品替代而導致市場佔有率下降的威脅有多大？
• Q11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球流感診斷市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2017-2028年市場趨勢及預測分析

• 宏觀經濟趨勢(2017-2022)與預測(2023-2028)
• 全球流感診斷市場趨勢(2017-2022)與預測(2023-2028)
• 依產品的全球流感診斷市場
  • 檢測套組和試劑
  • 儀器
  • 其他
• 按測試類型分類的全球流感診斷市場
  • 傳統測試
  • 分子診斷分析
  • 其他
• 依最終用途產業分類的全球流感診斷市場
  • 診斷實驗室
  • 醫院和診所
  • 其他

第4章 2017-2028年分地區市場趨勢及預測分析

• 全球流感診斷市場(依地區)
• 北美流感診斷市場
• 歐洲流感診斷市場
• 亞太流感診斷市場
• 其他區域流感診斷市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 依產品的全球流感診斷市場成長機會
  • 按測試類型分類的全球流感診斷市場成長機會
  • 依最終用途產業分類的全球流感診斷市場成長機會
  • 全球流感診斷市場區域成長機會
• 全球流感診斷市場新趨勢
• 戰略分析
  • 新產品開發
  • 全球流感診斷市場的產能擴張
  • 全球流感診斷市場的合併、收購與合資企業
  • 認證和許可

第7章 主要企業概況

• 3M
• Hoffmann-La Roche
• Becton, Dickinson and Company
• Thermo Fisher Scientific
• Hologic
• Quidel Corporation
• Abbott Laboratories
• Sekisui Diagnostics
• SA Scientific
• Meridian Bioscience

Influenza Diagnostic Market Trends and Forecast

The future of the global influenza diagnostic market looks promising with opportunities in the diagnostic laboratory and hospital & clinic markets. The global influenza diagnostic market is expected to reach an estimated $1.5 billion by 2028 with a CAGR of 4.1% from 2023 to 2028. The major drivers for this market are increasing number of chronic diseases, growing government initiatives to monitor influenza, and introduction of technologically advanced influenza diagnostics tests.

Influenza Diagnostic Market

A more than 150-page report is developed to help in your business decisions.

Influenza Diagnostic Market by Segment

The study includes trends and forecast for the global influenza diagnostic market by product, test type, end use industry, and region, as follows:

Influenza Diagnostic Market by Product [Shipment Analysis by Value from 2017 to 2028]:

• Test kits and reagents
• Instruments
• Others

Influenza Diagnostic Market by Test Type [Shipment Analysis by Value from 2017 to 2028]:

• Traditional Tests
• Molecular Diagnostic Assays
• Others

Influenza Diagnostic Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

• Diagnostic Laboratories
• Hospitals & Clinics
• Others

Influenza Diagnostic Market by Region [Shipment Analysis by Value from 2017 to 2028]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Influenza Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies influenza diagnostic companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the influenza diagnostic companies profiled in this report include:

• 3M
• Hoffmann-La Roche
• Becton, Dickinson and Company
• Thermo Fisher Scientific
• Hologic
• Quidel Corporation
• Abbott Laboratories
• Sekisui Diagnostics
• SA Scientific
• Meridian Bioscience

Influenza Diagnostic Market Insights

• Lucintel forecasts that molecular diagnostic assay will remain the largest segment over the forecast period due to increasing number of influenza research for diagnostic technologies along with rising awareness of early diagnosis of disease across the globe.
• Within this market, hospitals & clinics will remain the largest segment because of rising number of hospitals, growing awareness of influenza diagnostics among people, and increasing demand for rapid diagnostic testing equipment.
• North America will remain the largest region over the forecast period due to growing aging population, increasing prevalence of influenza, and existence of key players in this region.

Features of the Influenza Diagnostic Market

• Market Size Estimates: Influenza diagnostic market size estimation in terms of value ($B)
• Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
• Segmentation Analysis: Influenza diagnostic market size by various segments, such as by product, test type, end use industry, and region
• Regional Analysis: Influenza diagnostic market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
• Growth Opportunities: Analysis on growth opportunities in different by product, test type, end use industry, and regions for the influenza diagnostic market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape for the influenza diagnostic market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

• Q1. What is the influenza diagnostic market size?
• Answer: The global influenza diagnostic market is expected to reach an estimated $1.5 billion by 2028.
• Q2. What is the growth forecast for influenza diagnostic market?
• Answer: The global influenza diagnostic market is expected to grow with a CAGR of 4.1% from 2023 to 2028.
• Q3. What are the major drivers influencing the growth of the influenza diagnostic market?
• Answer: The major drivers for this market are increasing number of chronic diseases, growing government initiatives to monitor influenza, and introduction of technologically advanced influenza diagnostics tests.
• Q4. What are the major segments for influenza diagnostic market?
• Answer: The future of the global influenza diagnostic market looks promising with opportunities in the diagnostic laboratory and hospital & clinic markets.
• Q5. Who are the key influenza diagnostic companies?
• Answer: Some of the key influenza diagnostic companies are as follows:
  • 3M
  • Hoffmann-La Roche
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific
  • Hologic
  • Quidel Corporation
  • Abbott Laboratories
  • Sekisui Diagnostics
  • SA Scientific
  • Meridian Bioscience
• Q6. Which influenza diagnostic segment will be the largest in future?
• Answer:Lucintel forecasts that molecular diagnostic assay will remain the largest segment over the forecast period due to increasing number of influenza research for diagnostic technologies along with rising awareness of early diagnosis of disease across the globe.
• Q7. In influenza diagnostic market, which region is expected to be the largest in next 5 years?
• Answer: North America will remain the largest region over the forecast period due to growing aging population, increasing prevalence of influenza, and existence of key players in this region.
• Q8. Do we receive customization in this report?
• Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the global influenza diagnostic market by product (test kits and reagents, instruments, and others), test type (traditional tests, molecular diagnostic assays, and others), end use industry (diagnostic laboratories, hospitals & clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Influenza Diagnostic Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

• 3.1. Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
• 3.2. Global Influenza Diagnostic Market Trends (2017-2022) and Forecast (2023-2028)
• 3.3: Global Influenza Diagnostic Market by Product
  • 3.3.1 Test Kits and Reagents
  • 3.3.2 Instruments
  • 3.3.3 Others
• 3.4 Global Influenza Diagnostic Market by Test Type
  • 3.4.1 Traditional Tests
  • 3.4.2 Molecular Diagnostic Assays
  • 3.4.3 Others
• 3.5 Global Influenza Diagnostic Market by End Use Industry
  • 3.5.1 Diagnostic Laboratories
  • 3.5.2 Hospitals & Clinics
  • 3.5.3 Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

• 4.1: Global Influenza Diagnostic Market by Region
• 4.2: North American Influenza Diagnostic Market
  • 4.2.1: North American Influenza Diagnostic Market by Test Type: Traditional Tests, Molecular Diagnostic Assays, and Others
  • 4.2.2: North American Influenza Diagnostic Market by End Use Industry: Diagnostic Laboratories, Hospitals & Clinics, and Others
• 4.3: European Influenza Diagnostic Market
  • 4.3.1: European Influenza Diagnostic Market by Test Type: Traditional Tests, Molecular Diagnostic Assays, and Others
  • 4.3.2: European Influenza Diagnostic Market by End Use Industry: Diagnostic Laboratories, Hospitals & Clinics, and Others
• 4.4: APAC Influenza Diagnostic Market
  • 4.4.1: APAC Influenza Diagnostic Market by Test Type: Traditional Tests, Molecular Diagnostic Assays, and Others
  • 4.4.2: APAC Influenza Diagnostic Market by End Use Industry: Diagnostic Laboratories, Hospitals & Clinics, and Others
• 4.5: ROW Influenza Diagnostic Market
  • 4.5.1: ROW Influenza Diagnostic Market by Test Type: Traditional Tests, Molecular Diagnostic Assays, and Others
  • 4.5.2: ROW Influenza Diagnostic Market by End Use Industry: Diagnostic Laboratories, Hospitals & Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Influenza Diagnostic Market by Product
  • 6.1.2: Growth Opportunities for the Global Influenza Diagnostic Market by Test Type
  • 6.1.3: Growth Opportunities for the Global Influenza Diagnostic Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Influenza Diagnostic Market Region
• 6.2: Emerging Trends in the Global Influenza Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Influenza Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Influenza Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1 3M
• 7.2 Hoffmann-La Roche
• 7.3 Becton, Dickinson and Company
• 7.4 Thermo Fisher Scientific
• 7.5 Hologic
• 7.6 Quidel Corporation
• 7.7 Abbott Laboratories
• 7.8 Sekisui Diagnostics
• 7.9 SA Scientific
• 7.10 Meridian Bioscience